(19)
(11) EP 4 770 648 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24808799.1

(22) Date of filing: 31.10.2024
(51) International Patent Classification (IPC): 
A61K 31/675(2006.01)
A61P 1/00(2006.01)
A61K 45/06(2006.01)
A61P 11/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/675; A61P 11/00; A61P 1/00; A61K 45/06
(86) International application number:
PCT/US2024/053848
(87) International publication number:
WO 2025/096754 (08.05.2025 Gazette 2025/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 31.10.2023 US 202363594746 P

(71) Applicant: MUSC Foundation for Research Development
Charleston, SC 29425 (US)

(72) Inventors:
  • FEGHALI-BOSTWICK, Carol
    Mt. Pleasant, SC 20466 (US)
  • SHARMA, Shailza
    Charleston, SC 29414 (US)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)

   


(54) THE USE OF ENOLASE INHIBITOR POMHEX FOR TREATMENT OF FIBROSIS